Apr 23, 2024
1:80
For every 80 shares held, investors received 1. The price per share adjusted from $0.15 to $0.00.
The split itself did not change the total investment value.
Pieris Pharmaceuticals, Inc. (PIRS) trades on the NASDAQ Capital Market in the Biotechnology industry.
Pieris Pharmaceuticals, Inc. company overviewThe latest split shown was on April 23, 2024. It was a 1-for-80 reverse split, so shareholders received 1 share for every 80 they held.
This history records one reverse split, on April 23, 2024.